https://charts.traderzeitung.de/phases/US2307701092
string(1405) "{"isin":"US2307701092","name":"Cumberland Pharmaceuticals Inc","stock_id_xnas":7873639,"stock_id_xnys":null,"generated_at":"2026-09-24 01:33:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":7.48,"close_at":"2026-09-21 21:54:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":8.18,"close_at":"2026-09-22 21:50:00","complete":true,"perf_pct":9.3583},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":7.96,"close_at":"2026-09-23 21:56:00","complete":true,"perf_pct":-2.6895},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"
Cumberland Pharmaceuticals
Trading-Room

Cumberland Pharmaceuticals Aktie News & Nachrichten

[WKN: A0RC46 | Symbol: CPIX]
Realtimekurs
   
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Cumberland Pharmaceuticals gefunden werden.

Cumberland Pharmaceuticals Nachrichtenticker öffnen
MT Newswires 13.07.2026 17:27 Uhr

Cumberland beschließt Sonderdividende, genehmigt Aktienrückkaufprogramm im Wert von 5 Millionen US-Dollar

11:26 AM EDT, 07/13/2026 (MT Newswires) -- Cumberland Pharmaceuticals (CPIX) teilte am Montag mit, dass sein Vorstand eine Sonderdividende in bar von

MT Newswires 26.06.2026 21:43 Uhr

Sektor-Update: Gesundheitsaktien legen am späten Nachmittag zu

03:42 PM EDT, 06/26/2026 (MT Newswires) -- Gesundheitsaktien lagen am späten Freitagnachmittag höher, wobei der NYSE Healthcare Index um 2,2 % stieg u

MT Newswires 26.06.2026 19:34 Uhr

Sektor-Update: Gesundheitsaktien legen am Freitagnachmittag zu

01:33 PM EDT, 06/26/2026 (MT Newswires) -- Gesundheitsaktien notierten am Freitagnachmittag höher, wobei der NYSE Healthcare Index um 2,3 % stieg und

MT Newswires 26.06.2026 18:05 Uhr

Cumberland sagt, aktualisierte Daten unterstützen Ifetroban bei Duchenne-Muskeldystrophie-Kardiomyopathie

12:04 PM EDT, 06/26/2026 (MT Newswires) -- Die Aktien von Cumberland Pharmaceuticals (CPIX) stiegen am Freitagnachmittag im Handel um mehr als 5 %, na

MT Newswires 02.06.2026 15:52 Uhr

Cumberland Pharmaceuticals, Vanderbilt Health Berichten Positive Phase-2a-Ergebnisse für Ifetroban in einer Studie zur Metastasenvorbeugung

09:51 AM EDT, 06/02/2026 (MT Newswires) -- Cumberland Pharmaceuticals (CPIX) und Vanderbilt Health berichteten positive Phase-2a-Ergebnisse für Ifetro